Search Results - "de Boer, Mark G J"
-
1by van Boekel, Anna M, van der Meijden, Siri L, Arbous, Sesmu M, Nelissen, Rob G H H, Veldkamp, Karin E, Nieswaag, Emma B, Jochems, Kim F T, Holtz, Jeroen, Veenstra, Annekee van IJlzinga, Reijman, Jeroen, de Jong, Ype, van Goor, Harry, Wiewel, Maryse A, Schoones, Jan W, Geerts, Bart F, de Boer, Mark G J“…Surgical site infections (SSIs) lead to increased mortality and morbidity, as well as increased healthcare costs. Multiple models for the prediction of this…”
Published in PloS one (12. 12. 2024)
Journal Article -
2by de Boer, Mark G J, Jolink, Hetty, Halkes, Constantijn J M, van der Heiden, Pim L J, Kremer, Dennis, Falkenburg, J H Frederik, van de Vosse, Esther, van Dissel, Jaap T“…The innate immune system plays a pivotal role in the primary defence against invasive fungal infection. Genetic variation in genes that regulate this response,…”
Published in PloS one (04. 04. 2011)
Journal Article -
3by Westgeest, Annette C., Schippers, Emile F., Sijbom, Martijn, Visser, Leo G., de Boer, Mark G. J., Numans, Mattijs E., Lambregts, Merel M. C.“…The Dutch ‘search and destroy’ policy consists of screening patients with an increased risk of methicillin-resistant Staphylococcus aureus (MRSA) carriership…”
Published in Antibiotics (Basel) (01. 09. 2022)
Journal Article -
4by Lambregts, Merel M C, Hendriks, Bart J C, Visser, Leo G, Bernards, Sandra T, de Boer, Mark G J“…From a stewardship perspective it is recommended that antibiotic guidelines are adjusted to the local setting, accounting for the local epidemiology of…”
Published in Antimicrobial resistance & infection control (25. 01. 2019)
Journal Article -
5by Eikenboom, Anna M, Lambregts, Merel M C, de Boer, Mark G J, le Cessie, Saskia“…The diagnostic process is a key element of medicine but it is complex and prone to errors. Infectious diseases are one of the three categories of diseases in…”
Published in BMC infectious diseases (11. 04. 2024)
Journal Article -
6by Verheul, Mariëlle, Mulder, Aat A., van Dun, Sven C. J., Merabishvili, Maia, Nelissen, Rob G. H. H., de Boer, Mark G. J., Pijls, Bart G., Nibbering, Peter H.“…Metal-implant associated bacterial infections are a major clinical problem due to antibiotic treatment failure. As an alternative, we determined the effects of…”
Published in Scientific reports (22. 06. 2024)
Journal Article -
7by Chen, Qingui, Toorop, Myrthe M A, de Boer, Mark G J, Rosendaal, Frits R, Lijfering, Willem M“…To evaluate the association between crowding and transmission of viral respiratory infectious diseases, we investigated the change in transmission patterns of…”
Published in BMC public health (06. 10. 2020)
Journal Article -
8by Sijbom, Martijn, Braun, Karolina K, Büchner, Frederike L, van Bodegom-Vos, Leti, Hendriks, Bart J C, de Boer, Mark G J, Numans, Mattijs E, Lambregts, Merel M C“…Approximately 2% of patients in primary care practice and up to 25% of hospital patients are registered as being allergic to an antibiotic. However, up to 90%…”
Published in PloS one (07. 04. 2022)
Journal Article -
9by van Grootveld, Rebecca, Masarotto, Valentina, von dem Borne, Peter A, Blijlevens, Nicole M A, Chitu, Dana A, van der Beek, Martha T, Fiocco, Marta, de Boer, Mark G J“…Study objectives were to estimate the cumulative incidence of death due to different causes of death (CODs) and investigate the effect of invasive…”
Published in BMC infectious diseases (06. 02. 2023)
Journal Article -
10by Sieswerda, Elske, Bax, Hannelore I, Hoogerwerf, Jacobien J, de Boer, Mark G. J, Boermeester, Marja, Bonten, Marc J. M, Dekker, Douwe, van Wijk, Roy Gerth, Juffermans, Nicole P, Kuindersma, Marnix, van der Linden, Paul D, Melles, Damian C, Pickkers, Peter, Schouten, Jeroen A, Rebel, Jasper R, van Zanten, Arthur R. H, Prins, Jan M, Wiersinga, W. Joost“…The Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on…”
Published in BMC infectious diseases (11. 08. 2022)
Journal Article -
11by Nørgaard, Sarah Melissa, Jensen, Camilla Skaarup, Aalestrup, Josefine, Vandenbroucke-Grauls, Christina M J E, de Boer, Mark G J, Pedersen, Alma Becic“…Antimicrobial resistance is an increasingly serious threat to public health, and the increased occurrence of multidrug-resistant (MDR) bacteria is a concern in…”
Published in Antimicrobial resistance & infection control (04. 11. 2019)
Journal Article -
12by Eikenboom, Anna M, Le Cessie, Saskia, Waernbaum, Ingeborg, Groenwold, Rolf H H, de Boer, Mark G J“…Abstract Background Propensity score methods are becoming increasingly popular in infectious disease medicine to correct for confounding in observational…”
Published in Open forum infectious diseases (01. 04. 2022)
Journal Article -
13by de Boer, Mark G. J., Bruijnesteijn van Coppenraet, Lesla E. S., Gaasbeek, Andre, Berger, Stefan P., Gelinck, Luc B. S., van Houwelingen, Hans C., van den Broek, Peterhans, Kuijper, Ed J., Kroon, Frank P., Vandenbroucke, Jan P.“…Background. An outbreak of Pneumocystis jiroveci pneumonia (PCP) occurred among renal transplant recipients attending the outpatient department at the Leiden…”
Published in Clinical infectious diseases (01. 05. 2007)
Journal Article -
14by Welling, Mick M, Warbroek, Kim, Khurshid, Chrow, van Oosterom, Matthias N, Rietbergen, Daphne D D, de Boer, Mark G J, Nelissen, Rob G H H, van Leeuwen, Fijs W B, Pijls, Bart G, Buckle, Tessa“…Arthroplasty surgery of the knee and hip is performed in two to three million patients annually. Periprosthetic joint infections occur in 4% of these patients…”
Published in Bone & joint research (01. 01. 2023)
Journal Article -
15by Scheper, Henk, de Boer, Mark G. J.
Published in Journal of bone and joint infection (22. 07. 2020)Journal Article -
16by Laar, Sylvia A., Boer, Mark G. J., Gombert‐Handoko, Kim B., Guchelaar, Henk‐Jan, Zwaveling, Juliette“…For the treatment of Covid‐19 patients with remdesivir, poor renal and liver function were both exclusion criteria in randomized clinical trials and…”
Published in British journal of clinical pharmacology (01. 11. 2021)
Journal Article -
17by Scheper, Henk, Mahdad, Rachid, Elzer, Brenda, Löwik, Claudia, Zijlstra, Wierd, Gosens, Taco, van der Lugt, Joris C T, van der Wal, Robert J P, Poolman, Rudolf W, Somford, Matthijs P, Jutte, Paul C, Bos, Pieter K, Zwaan, Richard E, Nelissen, Rob G H H, Visser, Leo G, de Boer, Mark G J, The Wound Care App Study Group“…: Differentiation between uncomplicated and complicated postoperative wound drainage after arthroplasty is crucial to prevent unnecessary reoperation…”
Published in Journal of bone and joint infection (13. 02. 2023)
Journal Article -
18by de Boer, Mark G.J., van den Berk, Guido E.L., van Holten, Natasja, Oryszcyn, Josephine E., Dorama, Willemien, Moha, Daoud ait, Brinkman, Kees“…OBJECTIVE:Dolutegravir (DGV) is one of the preferred antiretroviral agents in first-line combination antiretroviral therapy (cART). Though considered to be a…”
Published in AIDS (London) (28. 11. 2016)
Journal Article -
19by Brunink, Elyne M., Hoogervorst, Lotje A., Steentjes, Koen, Broekhuis, Demien, de Boer, Mark G. J.“…Hematogenous osteomyelitis caused by Streptococcus intermedius is rare, particularly in immunocompetent adults. The aim of this paper is to provide an overview…”
Published in European journal of clinical microbiology & infectious diseases (01. 09. 2023)
Journal Article -
20by Sijbom, Martijn, Büchner, Frederike L, Saadah, Nicholas H, Numans, Mattijs E, de Boer, Mark G J“…ObjectivesThis study aimed to identify determinants of inappropriate antibiotic prescription in primary care in developed countries and to construct a…”
Published in BMJ open (17. 05. 2023)
Journal Article